4//SEC Filing
Beigelman Leonid 4
Accession 0001567619-23-005252
CIK 0001799448other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:10 PM ET
Size
5.7 KB
Accession
0001567619-23-005252
Insider Transaction Report
Form 4
Beigelman Leonid
DirectorPresident
Transactions
- Award
Stock Option (Right to Buy)
2023-03-15+169,500→ 169,500 totalExercise: $1.34Exp: 2033-03-15→ Common Stock (169,500 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from March 15, 2023 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001824721
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:10 PM ET
- Size
- 5.7 KB